162 related articles for article (PubMed ID: 35972045)
1. Targeting integrin αvβ6 with gallium-68 tris (hydroxypyridinone) based PET probes.
Floresta G; Memdouh S; Pham T; Ma MT; Blower PJ; Hider RC; Abbate V; Cilibrizzi A
Dalton Trans; 2022 Aug; 51(34):12796-12803. PubMed ID: 35972045
[TBL] [Abstract][Full Text] [Related]
2. In Vivo PET Imaging of the Cancer Integrin αvβ6 Using
Notni J; Reich D; Maltsev OV; Kapp TG; Steiger K; Hoffmann F; Esposito I; Weichert W; Kessler H; Wester HJ
J Nucl Med; 2017 Apr; 58(4):671-677. PubMed ID: 27980050
[TBL] [Abstract][Full Text] [Related]
3.
Ren J; Zhu S; Zhang G; Tan X; Qiu L; Lin J; Jiang L
Mol Pharm; 2022 Jul; 19(7):2620-2628. PubMed ID: 35674464
[TBL] [Abstract][Full Text] [Related]
4. PET/CT imaging of head-and-neck and pancreatic cancer in humans by targeting the "Cancer Integrin" αvβ6 with Ga-68-Trivehexin.
Quigley NG; Steiger K; Hoberück S; Czech N; Zierke MA; Kossatz S; Pretze M; Richter F; Weichert W; Pox C; Kotzerke J; Notni J
Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1136-1147. PubMed ID: 34559266
[TBL] [Abstract][Full Text] [Related]
5. Enhancing PET Signal at Target Tissue in Vivo: Dendritic and Multimeric Tris(hydroxypyridinone) Conjugates for Molecular Imaging of α
Imberti C; Terry SY; Cullinane C; Clarke F; Cornish GH; Ramakrishnan NK; Roselt P; Cope AP; Hicks RJ; Blower PJ; Ma MT
Bioconjug Chem; 2017 Feb; 28(2):481-495. PubMed ID: 27966893
[TBL] [Abstract][Full Text] [Related]
6. New Tris(hydroxypyridinone) Bifunctional Chelators Containing Isothiocyanate Groups Provide a Versatile Platform for Rapid One-Step Labeling and PET Imaging with (68)Ga(3.).
Ma MT; Cullinane C; Imberti C; Baguña Torres J; Terry SY; Roselt P; Hicks RJ; Blower PJ
Bioconjug Chem; 2016 Feb; 27(2):309-18. PubMed ID: 26286399
[TBL] [Abstract][Full Text] [Related]
7. Development and characterization of a
Ui T; Ueda M; Higaki Y; Kamino S; Sano K; Kimura H; Saji H; Enomoto S
Bioorg Med Chem; 2020 Jan; 28(1):115189. PubMed ID: 31740201
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the RGD Motif-Containing α
Roesch S; Lindner T; Sauter M; Loktev A; Flechsig P; Müller M; Mier W; Warta R; Dyckhoff G; Herold-Mende C; Haberkorn U; Altmann A
J Nucl Med; 2018 Nov; 59(11):1679-1685. PubMed ID: 29674419
[TBL] [Abstract][Full Text] [Related]
9. [(68)Ga]FSC-(RGD)3 a trimeric RGD peptide for imaging αvβ3 integrin expression based on a novel siderophore derived chelating scaffold-synthesis and evaluation.
Knetsch PA; Zhai C; Rangger C; Blatzer M; Haas H; Kaeopookum P; Haubner R; Decristoforo C
Nucl Med Biol; 2015 Feb; 42(2):115-22. PubMed ID: 25459110
[TBL] [Abstract][Full Text] [Related]
10. Clinical Translation of a
Feng X; Wang Y; Lu D; Xu X; Zhou X; Zhang H; Zhang T; Zhu H; Yang Z; Wang F; Li N; Liu Z
J Nucl Med; 2020 Oct; 61(10):1461-1467. PubMed ID: 32086242
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Copper-64-Labeled α
Ganguly T; Bauer N; Davis RA; Hausner SH; Tang SY; Sutcliffe JL
Mol Pharm; 2021 Dec; 18(12):4437-4447. PubMed ID: 34783573
[TBL] [Abstract][Full Text] [Related]
12. PET/CT Imaging of NSCLC with a α
Flechsig P; Lindner T; Loktev A; Roesch S; Mier W; Sauter M; Meister M; Herold-Mende C; Haberkorn U; Altmann A
Mol Imaging Biol; 2019 Oct; 21(5):973-983. PubMed ID: 30671741
[TBL] [Abstract][Full Text] [Related]
13. The Effects of an Albumin Binding Moiety on the Targeting and Pharmacokinetics of an Integrin α
Hausner SH; Bauer N; Davis RA; Ganguly T; Tang SYC; Sutcliffe JL
Mol Imaging Biol; 2020 Dec; 22(6):1543-1552. PubMed ID: 32383076
[TBL] [Abstract][Full Text] [Related]
14. 18F-fluorobenzoate-labeled cystine knot peptides for PET imaging of integrin αvβ6.
Hackel BJ; Kimura RH; Miao Z; Liu H; Sathirachinda A; Cheng Z; Chin FT; Gambhir SS
J Nucl Med; 2013 Jul; 54(7):1101-5. PubMed ID: 23670900
[TBL] [Abstract][Full Text] [Related]
15. Hydroxypyridinone Chelators: From Iron Scavenging to Radiopharmaceuticals for PET Imaging with Gallium-68.
Cusnir R; Imberti C; Hider RC; Blower PJ; Ma MT
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28075350
[TBL] [Abstract][Full Text] [Related]
16. Validation of In-House Kit-Like Synthesis of
Thakral P; Das SS; Dhiman S; Manda D; Virupakshappa CB; Malik D; Sen I
Cancer Biother Radiopharm; 2023 Sep; 38(7):468-474. PubMed ID: 37093129
[No Abstract] [Full Text] [Related]
17. Improvement of biodistribution profile of a radiogallium-labeled, αvβ6 integrin-targeting peptide probe by incorporation of negatively charged amino acids.
Nakamura S; Matsuno A; Ueda M
Ann Nucl Med; 2020 Aug; 34(8):575-582. PubMed ID: 32514725
[TBL] [Abstract][Full Text] [Related]
18. Preclinical Evaluation of
Ganguly T; Bauer N; Davis RA; Foster CC; Harris RE; Hausner SH; Roncali E; Tang SY; Sutcliffe JL
J Nucl Med; 2023 Apr; 64(4):639-644. PubMed ID: 36207137
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Radiopharmaceuticals Targeting Integrin αvβ6.
Färber SF; Wurzer A; Reichart F; Beck R; Kessler H; Wester HJ; Notni J
ACS Omega; 2018 Feb; 3(2):2428-2436. PubMed ID: 30023833
[TBL] [Abstract][Full Text] [Related]
20. Preclinical evaluation of a dual-receptor targeted tracer [
Lv X; Song X; Long Y; Zeng D; Lan X; Gai Y
Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):54-67. PubMed ID: 37642706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]